LONCASTUXIMAB TESIRINE

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:40:39 GMT 2023` Edited by `admin` on `Sat Dec 16 13:40:39 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	7K5O7P6QIU
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

LONCASTUXIMAB TESIRINE

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL RB4V1.2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RB4V1.2 .KAPPA.-CHAIN, DIMER, BIS(THIOETHER) WITH N-(31-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1,29-DIOXO-4,

Systematic Name

English

loncastuximab tesirine [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD-19)CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO AN AVERAGE OF TWO MOLECULES OF TESIRINE.GAMMA.1 HEAVY CHAIN (1-449) (MUS MUSCULUS VH (IGHV1-69*02 (86%) (IGHD)-IGHJ4*01)) (8.8.13) (1-120) -

Systematic Name

English

Loncastuximab tesirine [WHO-DD]

Common Name

English

ADCT-402

Code

English

LONCASTUXIMAB TESIRINE [USAN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

572816

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

FDA ORPHAN DRUG

572716

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

Code System Code Type Description

CAS

1879918-31-6

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

PRIMARY

NCI_THESAURUS

C125549

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

PRIMARY

USAN

FG-29

Created by admin on Sat Dec 16 13:40:40 GMT 2023 , Edited by admin on Sat Dec 16 13:40:40 GMT 2023

PRIMARY

DAILYMED

7K5O7P6QIU

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

PRIMARY

FDA UNII

7K5O7P6QIU

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

PRIMARY

WIKIPEDIA

Loncastuximab tesirine

Created by admin on Sat Dec 16 13:40:40 GMT 2023 , Edited by admin on Sat Dec 16 13:40:40 GMT 2023

PRIMARY

RXCUI

2540964

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

PRIMARY

INN

10586

Created by admin on Sat Dec 16 13:40:39 GMT 2023 , Edited by admin on Sat Dec 16 13:40:39 GMT 2023

PRIMARY

From	To
1_22	1_96
1_147	1_203
1_264	1_324
1_370	1_428
2_22	2_96
2_147	2_203
2_264	2_324
2_370	2_428
1_223	3_211
1_229	2_229
1_232	2_223
2_232	4_211
3_23	3_87
3_131	3_191
4_23	4_87
4_131	4_191

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_300
N	2_300

Related Record Type Details


					IYZ9TI08W3

B-LYMPHOCYTE ANTIGEN CD19

TARGET->CONJUGATED TOXIN

LONCASTUXIMAB TESIRINE-LPYL

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					7K5O7P6QIU

LONCASTUXIMAB TESIRINE

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL